The employee absenteeism costs of inflammatory bowel disease: Evidence from US national survey data

Journal of Occupational and Environmental Medicine

Volumn 55, Issue 4, 2013, Pages 393-401

  Gunnarsson, Candace ^a   Chen, Jie ^b   Rizzo, John A ^c   Ladapo, Joseph A ^d   Naim, Ahmad ^e   Lofland, Jennifer H ^e  

^a S2 Statistical Solutions Inc   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e Janssen Scientific Affairs LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; BRONCHITIS; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EMPHYSEMA; EMPLOYEE ATTITUDE; ENTERITIS; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HEART FAILURE; HISPANIC; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; WORKING TIME;

ABSENTEEISM; ADOLESCENT; ADULT; AGE DISTRIBUTION; COST OF ILLNESS; DATABASES, FACTUAL; EMPLOYMENT; FEMALE; HEALTH SURVEYS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84876406840     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31827cba48     Document Type: Article

References (47)

1. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
2. Pimentel M, Chang M, Chow EJ, et al. Identification of a prodromal period in Crohn's disease but not ulcerative colitis. Am J Gastroenterol. 2000;95:3458-3462.
3. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology. 1998;114:1161-1168.
4. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
5. Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984;29: 913-920.
6. Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990;98:104-110.
7. Roth MP, Petersen GM, McElree C, Feldman E, Rotter JI. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology. 1989;97:900-904.
8. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 1991;100:143-149.
9. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.
10. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002;122:875-880.
11. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Am J Gastroenterol. 2009;104:465-483.
12. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55:401-412.
13. Barreiro-de Acosta M, Domínguez-Muñoz JE, Núñez-Pardo de Vera MC, Lozano-León A, Lorenzo A, Peña A. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol. 2007;19:73-78.
14. Joo M, Abreu-e-Lima P, Farraye F, et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009;33:854-862.
15. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430-434.
16. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboem-bolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99: 97-101.
17. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950-954.
18. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology. 1991;100:1241-1248.
19. Cohen JL, Strong SA, Hyman NH, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2005;48:1997-2009.
20. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379-1386.
21. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gas-troenterol. 1992;14:309-317.
22. Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med. 2008;50:1261-1272.
23. Juan J, Estiarte R, Colome E, Artes M, Jimenez FJ, Alonso J. Burden of illness of Crohn's disease in Spain. Dig Liver Dis. 2003;35:853-861.
24. Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics. 2006;24:797-814.
25. Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single-centre retrospective study. Gut. 2004;53:1471-1478.
26. Longobardi T, Jacobs P, Wu L, Bernstein CN. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol. 2003;98:844-849.
27. Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin. 2008;24:319-328.
28. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. Survey Background. Agency for Healthcare Research and Quality Web site. Available at: http://www.meps.ahrq.gov/mepsweb/about meps/survey back.jsp. Updated August 21, 2009. Accessed March 12, 2009.
29. Cohen JW, Monheit AC, Beauregard KM, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996;33:373-389.
30. Cohen SB, DiGaetano R, Goksel H. Methodology report #5: estimation procedures in the 1996 MEPS household component. Agency for Healthcare Research and Quality Web site. Available at: http://meps.ahrq.gov/mepsweb/data files/publications/mr5/mr5.shtml. Accessed November 28, 2012.
31. Agency for Healthcare Research and Quality. MEPS-HC Response Rates by Panel. Agency for Healthcare Research and Quality Web site. Available at: http://meps.ahrq.gov/mepsweb/survey comp/hc response rate. jsp. Updated December 7, 2009. Accessed February 10, 2010.
32. Lee DW, Meyer JW, Clouse J. Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. Value Health. 2001;4:329-334.
33. Cragg JG. Some statistical models for limited dependent variables with application to the demand for durable goods. Econometrica. 1971;39: 829-844.
34. Buntin M, Zaslavsky A. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004; 23:525-542.
35. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998;17:247-281.
36. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78:605-610.
37. Berger ML, Murray JF, Xu J, Pauly M. Alternative valuations of work loss and productivity. J Occup Environ Med. 2001;43:18-24.
38. Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am J Manag Care. 2007;13:211-217.
39. Mitchell RJ, Bates P. Measuring health-related productivity loss. Popul Health Manag. 2011;14:93-98.
40. Nicholson S, Pauly MV, Polsky D, Sharda C, Szrek H, Berger ML. Measuring the effects of work loss on productivity with team production. Health Econ. 2006;15:111-123.
41. Drummond M. Cost-of-illness studies: a major headache? Pharmacoeco-nomics. 1992;2:1-4.
42. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60:3546-3553.
43. Shanahan F, Bernstein CN. Theevolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol. 2009;25:301-305.
44. US Census Bureau. Section 12: labor force, employment, and earnings. The 2011 Statistical Abstract Web site. Available at: http://www.census.gov/prod/ 2011pubs/11statab/labor.pdf. Updated January 6, 2011. Accessed March 6, 2011.
45. Lichtenstein GR, Yan S, Bala M, Hanauer S. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol. 2004;99:91-96.
46. Machlin S, Cohen J, Elixhauser A, Beauregard K, Steiner C. Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care. 2009;47:618-625.
47. Agency for Healthcare Research and Quality. MEPS HC-006R: 1996 Medical Conditions. Agency for Healthcare Research and Quality Web site. Available at: http://meps.ahrq.gov/mepsweb/data stats/download data/pufs/h06r/h06rdoc.shtml. Accessed March 12, 2010.